- Home
- CVAC vs ADTN Comparison
CVAC vs ADTN Comparison
Compare CVAC & ADTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVAC
- ADTN
- Stock Information
- Founded
- CVAC 2000
- ADTN 1985
- Country
- CVAC Germany
- ADTN United States
- Employees
- CVAC N/A
- ADTN N/A
- Industry
- CVAC Biotechnology: Pharmaceutical Preparations
- ADTN Telecommunications Equipment
- Sector
- CVAC Health Care
- ADTN Telecommunications
- Exchange
- CVAC Nasdaq
- ADTN Nasdaq
- Market Cap
- CVAC 818.8M
- ADTN 831.1M
- IPO Year
- CVAC 2020
- ADTN 1994
- Fundamental
- Price
- CVAC $2.72
- ADTN $8.82
- Analyst Decision
- CVAC Hold
- ADTN Strong Buy
- Analyst Count
- CVAC 3
- ADTN 4
- Target Price
- CVAC $10.00
- ADTN $13.50
- AVG Volume (30 Days)
- CVAC 634.5K
- ADTN 1.2M
- Earning Date
- CVAC 05-22-2025
- ADTN 05-05-2025
- Dividend Yield
- CVAC N/A
- ADTN N/A
- EPS Growth
- CVAC N/A
- ADTN N/A
- EPS
- CVAC N/A
- ADTN N/A
- Revenue
- CVAC $70,565,734.00
- ADTN $922,720,000.00
- Revenue This Year
- CVAC $742.57
- ADTN $14.44
- Revenue Next Year
- CVAC N/A
- ADTN $9.66
- P/E Ratio
- CVAC N/A
- ADTN N/A
- Revenue Growth
- CVAC 75.11
- ADTN N/A
- 52 Week Low
- CVAC $2.22
- ADTN $4.34
- 52 Week High
- CVAC $5.28
- ADTN $12.44
- Technical
- Relative Strength Index (RSI)
- CVAC 36.80
- ADTN 38.52
- Support Level
- CVAC $2.78
- ADTN $8.76
- Resistance Level
- CVAC $3.33
- ADTN $9.65
- Average True Range (ATR)
- CVAC 0.15
- ADTN 0.36
- MACD
- CVAC -0.01
- ADTN 0.01
- Stochastic Oscillator
- CVAC 1.61
- ADTN 34.13
About CVAC CureVac N.V.
CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid, or mRNA. The company was founded in 2000 and had its initial public offering in August 2020. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and Covid vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.
About ADTN ADTRAN Holdings Inc.
Adtran Holdings Inc is a provider of networking and communications platforms, software, and services focused on the broadband access market. It operates under two reportable segments: Network Solutions, which includes hardware and software products that enable a digital future that supports the company's Subscriber, Access & Aggregation, and Optical Networking Solutions; and Services & Support Segment which includes network design, implementation, maintenance and cloud-hosted services supporting the company's Subscriber, Access & Aggregation, and Optical Networking Solutions.